Oruka Therapeutics is a biopharmaceutical company focused on developing novel biologics aimed at treating chronic skin diseases, particularly plaque psoriasis and psoriatic arthritis
Oruka Therapeutics is a biopharmaceutical company focused on developing novel biologics aimed at treating chronic skin diseases, particularly plaque psoriasis and psoriatic arthritis. The company is advancing monoclonal antibodies designed to provide higher rates of complete disease clearance with fewer doses.